diallyl trisulfide has been researched along with Heart Disease, Ischemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Hsieh, MH; Hu, HY; Lin, KJ; Sung, HW; Tsai, HW; Wei, HJ; Wu, ZY | 1 |
| Cong, S; Ji, M; Liu, H; Lu, Y; Tao, H; Wang, W; Wang, X; Wei, L; Zhang, B; Zhao, Y | 1 |
| Cui, YJ; Guo, JZ; Li, B; Shi, ZX; Wang, BB; Zhang, WJ | 1 |
3 other study(ies) available for diallyl trisulfide and Heart Disease, Ischemic
| Article | Year |
|---|---|
An in situ slow-releasing H
Topics: Allyl Compounds; Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Delayed-Action Preparations; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Sulfide; Mice; Myocardial Ischemia; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Sulfides | 2019 |
Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia-reperfusion injury.
Topics: Allyl Compounds; Animals; Cardiotonic Agents; Cell Line; Delayed-Action Preparations; Ferric Compounds; Heart; Homeostasis; Hydrogen Sulfide; Male; Mice; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nanoparticles; Sulfides | 2019 |
Allitridum mimics effect of ischemic preconditioning by activation of protein kinase C.
Topics: Allyl Compounds; Animals; Enzyme Activation; Female; Garlic; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Polymyxin B; Protein Kinase C; Rabbits; Sulfides | 2001 |